George Wilkinson

Directeur/Membre du Conseil chez OREXO AB Fortune : 34 717 $ au 30/06/2026

Profil

George Frederick Wilkinson currently works at PLIVA dd, as Director-Supervisory Board from 2009, Orexo AB, as Independent Director from 2019, and Alter Pharma Group NV, as Independent Director.
Mr. Wilkinson also formerly worked at Catalent JNP, Inc., as President & Chief Executive Officer from 2001 to 2006, Impax Laboratories LLC, as President, Chief Executive Officer & Director from 2014 to 2016, Catalent JNP, Inc., as Director from 2010 to 2014, Barr Pharmaceuticals, Inc., as Director in 2009, Moksha8 Pharmaceuticals, Inc., as Director, Somerset Pharmaceuticals, Inc., as Director, Teva Women's Health, Inc., as President & Chief Operating Officer from 2006 to 2009, Actavis, Inc., as Chief Operating Officer & Senior Vice President in 2001, Sandoz Pharmaceuticals Corp., as Principal, and Allergan UC, as President-Global Research & Development in 2014.
Mr. Wilkinson received his Masters Business Admin degree in 1984 from Capital University and undergraduate degree in 1979 from Ohio Northern University.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
OREXO AB 0,04 %	31/12/2025	14 000 ( 0,04 % )	34 717 $	30/06/2026

Postes actifs de George Wilkinson

Sociétés	Poste	Début
OREXO AB	Directeur/Membre du Conseil	11/04/2019
PLIVA dd	Directeur/Membre du Conseil	06/10/2009
Alter Pharma Group NV	Directeur/Membre du Conseil	-

Anciens postes connus de George Wilkinson

Sociétés	Poste	Fin
Impax Laboratories LLC	Directeur Général	19/12/2016
ALLERGAN PLC	Directeur Technique/Scientifique/R&D	25/04/2014
JUNIPER PHARMACEUTICALS INC	Directeur/Membre du Conseil	06/03/2014
Teva Women's Health, Inc.	President	01/01/2009
BARR PHARMACEUTICALS INC	Directeur/Membre du Conseil	01/01/2009